ARMATA PHARMACEUTICALS INC (ARMP)
US04216R1023 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 37.86M | 13.52M | 14.85M | 10.29M | 9.65M | |||
| Receivables | 1.71M | 3.36M | N/A | N/A | N/A | |||
| Other Current Assets | 2.14M | 2.27M | 12.20M | 4.71M | 1.20M | |||
| Total Current Assets | 41.72M | 19.15M | 27.05M | 15.00M | 10.85M | |||
| Non-Current Assets | ||||||||
| PPE Net | 56.94M | 57.28M | 46.65M | 38.07M | 12.84M | |||
| Goodwill | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M | |||
| Intangibles | 10.26M | 10.26M | 10.26M | 10.26M | 10.26M | |||
| Other Non-Current Assets | 7.95M | 8.19M | 8.39M | 2.96M | 2.09M | |||
| Total Non-Current Assets | 78.64M | 79.21M | 68.78M | 54.77M | 28.67M | |||
| TOTAL ASSETS | 120.36M | 98.36M | 95.83M | 69.77M | 39.52M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 71.66M | 0.00 | 0.00 | 0.00 | 720.00K | |||
| Current Portion Of LT Debt. | 25.01M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 9.18M | 11.33M | 20.55M | 3.15M | 2.84M | |||
| Accounts Payable | 3.87M | 4.61M | 4.33M | 1.67M | 1.21M | |||
| Other Current Liabilities | 322.00K | 523.00K | N/A | 0.00 | 1.94M | |||
| Total Current Liabilities | 110.05M | 16.46M | 24.87M | 4.81M | 6.71M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 35.37M | 82.31M | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M | |||
| Other Non-Current Liabilities | 28.38M | 28.58M | 31.80M | 36.48M | 10.88M | |||
| Total Non-Current Liabilities | 66.82M | 113.97M | 34.88M | 39.56M | 13.95M | |||
| TOTAL LIABILITIES | 176.87M | 130.43M | 59.75M | 44.37M | 20.66M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -333.84M | -308.82M | -239.77M | -202.86M | -179.70M | |||
| Additional Paid In Capital | 276.97M | 276.39M | 275.49M | 227.98M | 198.37M | |||
| Common Shares | 361.00K | 361.00K | 360.00K | 270.00K | 190.00K | |||
| Shares Outstanding | 36.13M | 36.12M | 36.14M | 27.11M | 18.69M | |||
| Tangible Book Value per Share | -1.94 | -1.27 | 0.62 | 0.43 | 0.27 | |||
| Total Shareholders' Equity | -56.51M | -32.06M | 36.08M | 25.40M | 18.86M | |||
| TOTAL LIABILITIES AND EQUITY | 120.36M | 98.36M | 95.83M | 69.77M | 39.52M | |||
| Statistics | ||||||||
| Debt/Equity | -1.89 | -2.57 | N/A | N/A | N/A | |||
| Current Ratio | 0.38 | 1.16 | 1.09 | 3.12 | 1.62 | |||
| Return On Assets (ROA) | -66.12% | -70.19% | -38.53% | -33.19% | -56.12% | |||
| Return On Equity (ROE) | N/A | N/A | -102.33% | -91.18% | -117.60% | |||
All data in USD